MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works

Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line

Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · see citing works

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578 · see citing works

The evolution of gene regulation by transcription factors and microRNAs

Chen, K., & Rajewsky, N. (2007) · Nature Reviews Genetics · doi:10.1038/nrg1990 · Cited by 1,547 · see citing works

The MicroRNA miR-124 Promotes Neuronal Differentiation by Triggering Brain-Specific Alternative Pre-mRNA Splicing

Makeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · see citing works

Trinucleotide repeat length instability and age of onset in Huntington's disease

Duyao, M., Ambrose, C., Myers, R., Novelletto, A., Persichetti, F., Frontali, M., Folstein, S., Ross, C., Franz, M., Abbott, M., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-387 · Cited by 1,089 · see citing works

A microRNA array reveals extensive regulation of microRNAs during brain development

KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040 · see citing works

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

Kartner, N., Evernden-Porelle, D., Bradley, G., & Ling, V. W. T. (1985) · Nature · doi:10.1038/316820a0 · Cited by 908 · see citing works

Regional and cellular gene expression changes in human Huntington's disease brain

Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl013 · Cited by 804 · see citing works

Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth

Wang, X., Tang, S., Le, S., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 736 · see citing works

The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease

Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2390-08.2008 · Cited by 679 · see citing works

P-glycoprotein deficiency at the blood-brain barrier increases amyloid- deposition in an Alzheimer disease mouse model

Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · see citing works

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T., & Salmon, S. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.415 · Cited by 556 · see citing works

Huntingtin and the molecular pathogenesis of Huntington's disease

Landles, C., & Bates, G. P. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400250 · Cited by 485 · see citing works

The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer Cells

Mertens‐Talcott, S. U., Chintharlapalli, S. R., Li, X., & Safe, S. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2416 · Cited by 470 · see citing works

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

Hua Zhu, C., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C., & Yang, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 457 · see citing works

Diversity of microRNAs in human and chimpanzee brain

Berezikov, E., Thuemmler, F., van Laake, L. W., Kondova, I., Bontrop, R., Cuppen, E., & Plasterk, R. H. A. (2006) · Nature Genetics · doi:10.1038/ng1914 · Cited by 416 · see citing works

β‐Amyloid efflux mediated by p‐glycoprotein

Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 379 · see citing works

A microRNA-based gene dysregulation pathway in Huntington's disease

Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E. F., & Buckley, N. J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.001 · Cited by 360 · see citing works

Deposition of Alzheimer's ??-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans

Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund, W., Kunert‐Keil, C., Walker, L. C., & Warzok, R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00005 · Cited by 345 · see citing works

Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer’s Disease

Hartz, A. M. S., Miller, D. S., & Bauer, B. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061754 · Cited by 319 · see citing works

microRNA-34c is a novel target to treat dementias

Zovoilis, A., Agbemenyah, H. Y., Agis‐Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.327 · Cited by 298 · see citing works

Altered microRNA regulation in Huntington's disease models

Lee, S., Chu, K., Im, W., Yoon, H., Im, J.-Y., Park, J.-E., Park, K.-H., Jung, K., Lee, S. K., Kim, M., et al. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.10.012 · Cited by 289 · see citing works

The involvement of microRNAs in neurodegenerative diseases

Maciotta, S., Meregalli, M., & Torrente, Y. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00265 · Cited by 247 · see citing works

Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15

Stine, O. C., Pleasant, N. D., Franz, M. L., Abbott, M. H., Folstein, S. E., & Ross, C. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1547 · Cited by 233 · see citing works

Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[11C]verapamil and positron emission tomography

Toornvliet, R., vanBerckel, B. N., Luurtsema, G., Lubberink, M., Geldof, A. A., Bosch, T. M., Oerlemans, R., Lammertsma, A. A., & Franssen, E. J. F. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.02.004 · Cited by 190 · see citing works

MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells

Li, Z., Hu, S., Wang, J., Cai, J., Xiao, L., Yu, L., & Wang, Z. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.06.004 · Cited by 183 · see citing works

miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition

Zhang, Z., Liu, S., Shi, R., & Zhao, G. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.004 · Cited by 162 · see citing works

Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma

Zhang, H., Li, M., Han, Y., Hong, L., Gong, T., Sun, L., & Zheng, X. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1051-6 · Cited by 136 · see citing works

Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

Zhao, X., Li, Y., & Hu, J. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-55 · Cited by 133 · see citing works

miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and Induced Pluripotent Stem Cell Models

Cheng, P., Li, C.-L., Chang, Y.-F., Tsai, S.-J., Lai, Y.-Y., Chan, A. W. S., Chen, C., & Yang, S. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.025 · Cited by 111 · see citing works

MicroRNA in central nervous system trauma and degenerative disorders

Liu, N., & Xu, X. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00168.2010 · Cited by 109 · see citing works

A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid ? -Peptide from the Brain

Wang, W., M. Bodles-Brakhop, A., & W. Barger, S. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160314151012 · Cited by 107 · see citing works

Huntington??s disease: present treatments and future therapeutic modalities

Bonelli, R. M., Wenning, G. K., & Kapfhammer, H. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00001 · Cited by 92 · see citing works

Micro RNA -214,-150,-146a and-125b targetHuntingtingene

Sinha, M., Ghose, J., & Bhattarcharyya, N. P. (2011) · RNA Biology · doi:10.4161/rna.8.6.16035 · Cited by 81 · see citing works

MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice

Zhang, Y., Liu, C., Wang, J., Li, Q., Ping, H., Gao, S., & Wang, P. (2016) · Scientific Reports · doi:10.1038/srep24566 · Cited by 73 · see citing works

Advances in the Pharmacological Management of Huntingtonʼs Disease

Frank, S., & Jankovic, J. J. (2010) · Drugs · doi:10.2165/11534430-000000000-00000 · Cited by 70 · see citing works

miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer

Huang, D., Wang, H., Liu, R., Li, H., Ge, S., Bai, M., Deng, T., Yao, G., & Ba, Y. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24689 · Cited by 65 · see citing works

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model

Im, W., Ban, J., Chung, J. Y., Lee, S., Chu, K., & Kim, M. (2015) · Scientific Reports · doi:10.1038/srep16887 · Cited by 21 · see citing works

Neurodegeneration Caused by Polyglutamine Expansion Is Regulated by P-Glycoprotein in Drosophila melanogaster

Yadav, S., & Tapadia, M. G. (2013) · Genetics · doi:10.1534/genetics.113.155077 · Cited by 12 · see citing works

Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells

Ban, J.-J., Yang, S., Im, W., & Kim, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148691 · Cited by 6 · see citing works

Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases

Wu, Y.-Y., & Kuo, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00636-z · Cited by 213 · see citing works

New Avenues for the Treatment of Huntington’s Disease

Kim, A. M., Lalonde, K. M., Truesdell, A., Welter, P. G., Brocardo, P. S., Rosenstock, T. R., & Gil‐Mohapel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168363 · Cited by 198 · see citing works

Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets

Loganathan, T., & Doss, C. G. P. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00947-4 · Cited by 190 · see citing works

miR-27a-3p protects against blood–brain barrier disruption and brain injury after intracerebral hemorrhage by targeting endothelial aquaporin-11

Xi, T., Jin, F., Zhu, Y., Wang, J., Tang, L. Y., Wang, Y., Liebeskind, D. S., Scalzo, F., & He, Z. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001858 · Cited by 115 · see citing works

Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders

Paul, S., Bravo-Vázquez, L. A., Uribe, S. P., Reyes‐Pérez, P., & Sharma, A. K. (2020) · Cells · doi:10.3390/cells9071698 · Cited by 104 · see citing works

RNA delivery biomaterials for the treatment of genetic and rare diseases

Zhao, W., Hou, X., Vick, O. G., & Dong, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119291 · Cited by 82 · see citing works

Epigenetic mechanisms of neurodegenerative diseases and acute brain injury

Bertogliat, M. J., Morris-Blanco, K. C., & Vemuganti, R. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104642 · Cited by 77 · see citing works

Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases

Li, D., Li, Y., Li, Y., Zhu, X., Du, X., Zhou, M., Li, W., & Deng, H. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.240817 · Cited by 55 · see citing works

Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders

Espinosa‐Parrilla, Y., González-Billault, C. E., Eduardo Fuentes, Q., Palomo, I. F., & Alarcón, M. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00151 · Cited by 49 · see citing works

Circular RNA Expression Profiles Alter Significantly after Traumatic Brain Injury in Rats

Xie, B., Wang, Y., Lin, Y., Zhao, C.-C., Mao, Q., Feng, J., Cao, J., Gao, G., & Jiang, J. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5468 · Cited by 47 · see citing works

MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?

Dong, X., & Cong, S. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.705348 · Cited by 48 · see citing works

miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability

Harati, R., Hammad, S., Tlili, A., Mahfood, M., Mabondzo, A. M., & Hamoudi, R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262152 · Cited by 47 · see citing works

Combination of stem cell and gene therapy ameliorates symptoms in Huntington’s disease mice

Cho, I. K., Hunter, C. E., Ye, S., Pongos, A. L. A., & Chan, A. W. S. (2019) · npj Regenerative Medicine · doi:10.1038/s41536-019-0066-7 · Cited by 45 · see citing works

A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson’s disease

Su, L., Wang, C., Zheng, C., Wei, H., & Song, X. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0357-7 · Cited by 44 · see citing works

Amelioration of Huntington’s disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington’s disease monkeys

Cho, I. K., Yang, B., Forest, C. R., Lü, Q., & Chan, A. W. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214156 · Cited by 34 · see citing works

Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers

Kobeissy, F. H., Kobaisi, A., Peng, W., Barsa, C., Goli, M., Sibahi, A., Hayek, S. E., Abdelhady, S., Haidar, M. A., Sabra, M., et al. (2022) · Cells · doi:10.3390/cells11030581 · Cited by 28 · see citing works

Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives

Hernaiz, A., Toivonen, J. M., Bolea, R., & Martín‐Burriel, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012609 · Cited by 24 · see citing works

The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington’s disease

Ghafouri‐Fard, S., Khoshbakht, T., Hussen, B. M., Taheri, M. N., Ebrahimzadeh, K., & Noroozi, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.987174 · Cited by 22 · see citing works

The Differentially Expressed Circular RNAs in the Substantia Nigra and Corpus Striatum of Nrf2-Knockout Mice

Yang, J., Zhang, R., Lin, J., Cao, M.-C., Wang, Q., Cui, H., Sun, S.-G., & Wang, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494478 · Cited by 21 · see citing works

A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich’s Ataxia Patients

Misiorek, J. O., Schreiber, A. M., Urbanek-Trzeciak, M. O., Jazurek, M., Hauser, L. A., Lynch, D. R., Napierala, J. S., & Напиерала, М. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01899-1 · Cited by 20 · see citing works

Bioinformatic analysis of a microRNA regulatory network in Huntington’s disease

Wang, Z.-M., Dong, X., & Cong, S. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.04.203 · Cited by 17 · see citing works

Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis

Dong, X., & Cong, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8410 · Cited by 14 · see citing works

Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases

Saleem, A., Javed, M., Akhtar, M. F., Sharif, A., Akhtar, B., Naveed, M., Saleem, U., Baig, M. M. F. A., Zubair, H. M., Emran, T. B., et al. (2023) · Current Gene Therapy · doi:10.2174/0115665232261931231006103234 · Cited by 14 · see citing works

Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review

Banazadeh, M., Abiri, A., Poortaheri, M. M., Asnaashari, L., Langarizadeh, M. A., & Forootanfar, H. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130413 · Cited by 12 · see citing works

Recent Advances in the miRNA-Mediated Regulation of Neuronal Differentiation and Death

Patranabis, S. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08820-2 · Cited by 12 · see citing works

Full sequence of mutant huntingtin 3′-untranslated region and modulation of its gene regulatory activity by endogenous microRNA

Kim, K., Elneel, K. A., Shin, J. W., Keum, J. W., Seong, D., Kwak, S., Lee, R., Gusella, J. F., MacDonald, M. E., Seong, I. S., et al. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0639-8 · Cited by 11 · see citing works

Neuroinflammation and the role of epigenetic-based therapies for Huntington’s disease management: the new paradigm

Temgire, P., Arthur, R., & Kumar, P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01477-0 · Cited by 8 · see citing works

The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease

Mansour, R. M., Shaker, A. A. S., Abulsoud, A. I., Mageed, S. S. A., Ashraf, A., Elsakka, E. G. E., Dahab, M. I., Sadek, M. M., Awad, F. A., Lutfy, R. H., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04750-7 · Cited by 5 · see citing works

Extracellular Vesicles as Possible Sources of Huntington’s Disease Biomarkers

Ananbeh, H., & Skalníková, H. K. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_3 · Cited by 3 · see citing works

Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity

Huang, Z.-N., Lee, S.-Y., Chen, J.-M., Huang, Z.-T., & Her, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1459909 · Cited by 3 · see citing works

MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies—advances and challenges

Azam, H. M. H., Mumtaz, M., Rödiger, S., Schierack, P., Hussain, N., & Ambreen, A. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08419-w · Cited by 3 · see citing works

Personalized epigenetics of neurodegenerative diseases

Gautam, V., Sandhu, A., Rawat, K., Kumar, A., & Saha, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23802-4.00020-x · Cited by 1 · see citing works

Huntington's disease: From large animal models to HD gene therapy

Yan, S., Li, X., & Li, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00014-5 · Cited by 1 · see citing works

MicroRNAs Regulating Autophagy in Neurodegeneration

Lai, Q., Kovzel, N., Konovalov, R., & Vinnikov, I. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-2830-6_11 · Cited by 1 · see citing works

Extracellular vesicles in neurodegenerative diseases

Singh, G., Prasad, S., Singh, C., & Singh, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36641-3.00008-5

MicroRNAs in polyglutamine diseases: Mechanistic insights, circulating biomarkers, and emerging microRNA-based therapeutic strategies

Liu, Y., Cui, Y., Sun, M., Gong, L., Liu, K., Zhang, S., Tan, X., & Cong, S. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107603

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model

Im, W., Ban, J., Chung, J. Y., Lee, S., Chu, K., & Kim, M. (2015) · Scientific Reports · doi:10.1038/srep16887 · Cited by 21 · see citing works

miR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington’s disease

Tung, C.-W., Chan, S. C., Chen, Y.-C., Wu, P., Cheng, P., Chen, C., & Yang, S. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01292-5

miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and Induced Pluripotent Stem Cell Models

Cheng, P., Li, C.-L., Chang, Y.-F., Tsai, S.-J., Lai, Y.-Y., Chan, A. W. S., Chen, C., & Yang, S. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.025 · Cited by 111 · see citing works

Altered microRNA expression in animal models of Huntington’s disease and potential therapeutic strategies

Peplow, P., & Martinez, B. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310673 · Cited by 31 · see citing works

Additional file 1 of miR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington’s disease

Tung, C.-W., Chan, S. C., Chen, Y.-C., Wu, P.-M., Cheng, P.-H., Chen, C.-M., & Yang, S. (2026) · Figshare · doi:10.6084/m9.figshare.33991756